Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

NCT04480580 is registered in ClinicalTrials.gov with University of Cagliari as lead sponsor.

NCT NCT04480580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04480580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery
Lead sponsor
University of Cagliari
Phase
Observational
Overall status
Completed
Start date
March 30, 2020
Completion date
June 30, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars (severe acute respiratory syndrome), surgery